Cargando…

Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization

Background: Diffuse large B-cell lymphoma (DLBCL), marginal zone lymphoma (MZL) and follicular lymphoma (FL) are the most common B-cell lymphomas (BCL) in dogs. Recent investigations have demonstrated overlaps of these histotypes with the human counterparts, including clinical presentation, biologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Cascione, Luciano, Giudice, Luca, Ferraresso, Serena, Marconato, Laura, Giannuzzi, Diana, Napoli, Sara, Bertoni, Francesco, Giugno, Rosalba, Aresu, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789837/
https://www.ncbi.nlm.nih.gov/pubmed/31546795
http://dx.doi.org/10.3390/ncrna5030047
_version_ 1783458704794845184
author Cascione, Luciano
Giudice, Luca
Ferraresso, Serena
Marconato, Laura
Giannuzzi, Diana
Napoli, Sara
Bertoni, Francesco
Giugno, Rosalba
Aresu, Luca
author_facet Cascione, Luciano
Giudice, Luca
Ferraresso, Serena
Marconato, Laura
Giannuzzi, Diana
Napoli, Sara
Bertoni, Francesco
Giugno, Rosalba
Aresu, Luca
author_sort Cascione, Luciano
collection PubMed
description Background: Diffuse large B-cell lymphoma (DLBCL), marginal zone lymphoma (MZL) and follicular lymphoma (FL) are the most common B-cell lymphomas (BCL) in dogs. Recent investigations have demonstrated overlaps of these histotypes with the human counterparts, including clinical presentation, biologic behavior, tumor genetics, and treatment response. The molecular mechanisms that underlie canine BCL are still unknown and new studies to improve diagnosis, therapy, and the utilization of canine species as spontaneous animal tumor models are undeniably needed. Recent work using human DLBCL transcriptomes has suggested that long non-coding RNAs (lncRNAs) play a key role in lymphoma pathogenesis and pinpointed a restricted number of lncRNAs as potential targets for further studies. Results: To expand the knowledge of non-coding molecules involved in canine BCL, we used transcriptomes obtained from a cohort of 62 dogs with newly-diagnosed multicentric DLBCL, MZL and FL that had undergone complete staging work-up and were treated with chemotherapy or chemo-immunotherapy. We developed a customized R pipeline performing a transcriptome assembly by multiple algorithms to uncover novel lncRNAs, and delineate genome-wide expression of unannotated and annotated lncRNAs. Our pipeline also included a new package for high performance system biology analysis, which detects high-scoring network biological neighborhoods to identify functional modules. Moreover, our customized pipeline quantified the expression of novel and annotated lncRNAs, allowing us to subtype DLBCLs into two main groups. The DLBCL subtypes showed statistically different survivals, indicating the potential use of lncRNAs as prognostic biomarkers in future studies. Conclusions: In this manuscript, we describe the methodology used to identify lncRNAs that differentiate B-cell lymphoma subtypes and we interpreted the biological and clinical values of the results. We inferred the potential functions of lncRNAs to obtain a comprehensive and integrative insight that highlights their impact in this neoplasm.
format Online
Article
Text
id pubmed-6789837
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67898372019-10-16 Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization Cascione, Luciano Giudice, Luca Ferraresso, Serena Marconato, Laura Giannuzzi, Diana Napoli, Sara Bertoni, Francesco Giugno, Rosalba Aresu, Luca Noncoding RNA Article Background: Diffuse large B-cell lymphoma (DLBCL), marginal zone lymphoma (MZL) and follicular lymphoma (FL) are the most common B-cell lymphomas (BCL) in dogs. Recent investigations have demonstrated overlaps of these histotypes with the human counterparts, including clinical presentation, biologic behavior, tumor genetics, and treatment response. The molecular mechanisms that underlie canine BCL are still unknown and new studies to improve diagnosis, therapy, and the utilization of canine species as spontaneous animal tumor models are undeniably needed. Recent work using human DLBCL transcriptomes has suggested that long non-coding RNAs (lncRNAs) play a key role in lymphoma pathogenesis and pinpointed a restricted number of lncRNAs as potential targets for further studies. Results: To expand the knowledge of non-coding molecules involved in canine BCL, we used transcriptomes obtained from a cohort of 62 dogs with newly-diagnosed multicentric DLBCL, MZL and FL that had undergone complete staging work-up and were treated with chemotherapy or chemo-immunotherapy. We developed a customized R pipeline performing a transcriptome assembly by multiple algorithms to uncover novel lncRNAs, and delineate genome-wide expression of unannotated and annotated lncRNAs. Our pipeline also included a new package for high performance system biology analysis, which detects high-scoring network biological neighborhoods to identify functional modules. Moreover, our customized pipeline quantified the expression of novel and annotated lncRNAs, allowing us to subtype DLBCLs into two main groups. The DLBCL subtypes showed statistically different survivals, indicating the potential use of lncRNAs as prognostic biomarkers in future studies. Conclusions: In this manuscript, we describe the methodology used to identify lncRNAs that differentiate B-cell lymphoma subtypes and we interpreted the biological and clinical values of the results. We inferred the potential functions of lncRNAs to obtain a comprehensive and integrative insight that highlights their impact in this neoplasm. MDPI 2019-09-19 /pmc/articles/PMC6789837/ /pubmed/31546795 http://dx.doi.org/10.3390/ncrna5030047 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cascione, Luciano
Giudice, Luca
Ferraresso, Serena
Marconato, Laura
Giannuzzi, Diana
Napoli, Sara
Bertoni, Francesco
Giugno, Rosalba
Aresu, Luca
Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization
title Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization
title_full Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization
title_fullStr Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization
title_full_unstemmed Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization
title_short Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization
title_sort long non-coding rnas as molecular signatures for canine b-cell lymphoma characterization
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789837/
https://www.ncbi.nlm.nih.gov/pubmed/31546795
http://dx.doi.org/10.3390/ncrna5030047
work_keys_str_mv AT cascioneluciano longnoncodingrnasasmolecularsignaturesforcaninebcelllymphomacharacterization
AT giudiceluca longnoncodingrnasasmolecularsignaturesforcaninebcelllymphomacharacterization
AT ferraressoserena longnoncodingrnasasmolecularsignaturesforcaninebcelllymphomacharacterization
AT marconatolaura longnoncodingrnasasmolecularsignaturesforcaninebcelllymphomacharacterization
AT giannuzzidiana longnoncodingrnasasmolecularsignaturesforcaninebcelllymphomacharacterization
AT napolisara longnoncodingrnasasmolecularsignaturesforcaninebcelllymphomacharacterization
AT bertonifrancesco longnoncodingrnasasmolecularsignaturesforcaninebcelllymphomacharacterization
AT giugnorosalba longnoncodingrnasasmolecularsignaturesforcaninebcelllymphomacharacterization
AT aresuluca longnoncodingrnasasmolecularsignaturesforcaninebcelllymphomacharacterization